Metraipolis › archive › dc_f92ee1e6be89

Government innovation subsidy, executives' academic capital and innovation quality: Evidence from pharmaceutical companies in China — Europe PMC PMID:36710848

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36710848
DOI
10.3389/fpsyg.2022.1092162
License (as archived)
solo-consultazione
Archived
2026-10-08T01:33:24.198Z
SHA-256 of the archived text
afd6eaff7706c34f6ca9e994d04034f7fdcc8487965bdc9f7dc42fab346acc49
Stable URL of this page
https://metraipolis.com/documento/dc_f92ee1e6be89

How to cite

Government innovation subsidy, executives' academic capital and innovation quality: Evidence from pharmaceutical companies in China — Europe PMC PMID:36710848 — Europe PMC (en), https://europepmc.org/article/MED/36710848 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f92ee1e6be89 (Metraipolis archive dc_f92ee1e6be89, sha256 afd6eaff7706c34f6ca9e994d04034f7fdcc8487965bdc9f7dc42fab346acc49)
BibTeX
@misc{dcf92ee1e6be89,
  title = {Government innovation subsidy, executives' academic capital and innovation quality: Evidence from pharmaceutical companies in China — Europe PMC PMID:36710848},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36710848},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f92ee1e6be89; sha256 afd6eaff7706c34f6ca9e994d04034f7fdcc8487965bdc9f7dc42fab346acc49},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36710848. Agents can read the archived copy with the MCP tool read_document.